COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Catheter Management After Pelvic Reconstructive Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03071211
Recruitment Status : Completed
First Posted : March 6, 2017
Last Update Posted : February 4, 2019
Information provided by (Responsible Party):
Sarah Boyd, Hartford Hospital

Brief Summary:
This is a randomized controlled trial comparing plug-unplug catheter management, continuous drainage catheter systems and patients that do not get discharged with catheters after inpatient pelvic reconstructive surgery.

Condition or disease Intervention/treatment Phase
Urinary Retention Postoperative Pelvic Organ Prolapse Device: Plug-unplug catheter management Device: Continuous drainage catheter management Not Applicable

Detailed Description:

This study will be a randomized controlled trial comparing plug-unplug (PUP) catheter management, continuous drainage (CD) catheter systems and patients that do not get discharged with catheters (reference) after pelvic reconstructive surgery. The primary objective of this study is to assess impact on activity. The secondary objectives are to compare the rate of urinary tract infection between the groups, duration of time (days) it takes for patients to resume normal voiding, impact on post-operative pain and satisfaction with surgery experience and post-operative recovery. The investigators hypothesize that patient activity/mobility one week after surgery between the two methods of managing the transurethral catheter will be different between arms. Subjects will be recruited at the Hartford Hospital Division of Female Pelvic Medicine and Reconstructive Surgery during preoperative consultation for pelvic reconstructive surgery with 1:1:1 assignment and randomization for PUP and CD groups only. Prior to surgery, baseline activity will be assessed using the Activity Assessment Scale, as well as postoperative expectations. Prior to hospital discharge, patients will undergo a postoperative voiding trial (PVT) per regular clinical practice. Upon failure of PVT, participants will be randomized 1:1 to one of two arms in which participants receive a catheter: PUP or CD. The investigator responsible for data collection will remain blinded to the treatment assignment throughout the study. Subjects who pass the PVT test and therefore do not require a catheter will be assigned to the reference arm (Arm C). Subjects will be followed after hospital discharge and assessed using the same pre- and post-operative questionnaires as participants randomized to the CD and PUP arms and will comprise the first 32 consenting patients who do not require a catheter.

Subjects randomized to CD will have a 16F transurethral catheter attached to a leg bag and receive teaching regarding home maintenance. Subjects randomized to PUP will have the same 16F transurethral catheter placed with a plastic plug and instructed to unplug and drain the catheter when they feel the urge to void, or at least every four hours throughout the day. Subjects in both groups will be provided a large bag for gravity-based drainage during the night. Subjects also will be encouraged to call the research team with any catheter-related questions or concerns including symptoms of urinary tract infection (UTI). Subjects with symptoms of UTI (e.g., dysuria, urgency, frequency, and/or hematuria) will be evaluated and treated per standard of care. All participants will then return for an office voiding trial (OVT) five to seven days after hospital discharge, following the same protocol as the PVT. At this time urinalysis will be obtained. Only those participants who endorse symptoms of UTI will have a urine specimen collected and sent for culture. This is in line with the current clinical practice by the investigators. Participants will be treated for UTI based on culture results or if there is high clinical suspicion at the time of office follow-up. Participants who fail the OVT will be discharged home with bladder drainage per standard of care and undergo routine follow-up until they pass a repeat voiding trial.

The subjects will complete a post-operative questionnaire assessing pain, impact on activity and satisfaction. Outcomes will be followed for up to six weeks after initial OVT if it is failed; however, no additional research-associated visits will be necessary from study participants beyond the initial office visit.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 96 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Catheter Management After Pelvic Reconstructive Surgery: a Randomized Controlled Trial
Actual Study Start Date : February 26, 2017
Actual Primary Completion Date : December 7, 2018
Actual Study Completion Date : January 31, 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Plug-unplug Group
Participants randomized to plug-unplug catheter management. Participants plug and unplug catheters when they feel urge to void or at least every 4 hours during the day. Participants are given the option to use a large drainage bag for convenience overnight.
Device: Plug-unplug catheter management
Transurethral catheter is plugged with a plastic cap and participants are taught to unplug during the day when they feel the urge to void or at least every 4 hours.

Active Comparator: Continuous Drainage Group
Participants randomized to continuous drainage catheter management. Catheters are attached to a leg bag during the day and large drainage bag for convenience overnight.
Device: Continuous drainage catheter management
Transurethral catheter is attached to a continuous drainage bag.

No Intervention: Reference Group
Participants that do not fail inpatient voiding trial and go home without a catheter.

Primary Outcome Measures :
  1. Activity Assessment Scale [ Time Frame: Postoperative day 3-5 ]
    Participants complete this 18-question survey preoperatively and 3-5 days postoperatively.

Secondary Outcome Measures :
  1. Preoperative expectations [ Time Frame: At the time of consent ]
    Patients complete a preoperative expectations survey prior to surgery.

  2. Days until passing voiding trial [ Time Frame: up to 6 weeks postoperatively ]
    Evaluate rates of passing voiding trial between arms

  3. Urinary Tract infection [ Time Frame: up to 6 weeks postoperatively ]
    Rates of urinary tract infection between arms

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Female
  • Age 18-89
  • Inpatient surgery
  • surgery for pelvic organ prolapse with or without mid-urethral slings who fail initial voiding trial at the time of hospital discharge
  • willing/able to provide written informed consent

Exclusion Criteria:

  • male
  • age < 18 or >89
  • unwilling or unable to provide written informed consent
  • undergoing outpatient surgery.
  • planned postoperative catheter use
  • discharged to a nursing facility or who are not candidates for the plug-unplug method for another reason (e.g., poor hand dexterity, paraplegia)
  • suprapubic catheter placement
  • procedures involving urethral bulking or Onabotulinum toxin A (Botox) injection
  • procedures involving planned urethral or bladder surgery (e.g., fistula excision, mesh excision, excision of urethral diverticulum)
  • procedures with only posterior vaginal repair
  • presence of a neurologic condition affecting urinary function

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03071211

Layout table for location information
United States, Connecticut
Hartford Hospital
Hartford, Connecticut, United States, 06106
Sponsors and Collaborators
Hartford Hospital
Layout table for investigator information
Principal Investigator: Sarah S Boyd, MD Hartford Hospital
Principal Investigator: Elena Tunitsky-Bitton, MD Hartford Hospital
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Sarah Boyd, Fellow physician, Hartford Hospital Identifier: NCT03071211    
Other Study ID Numbers: HHC-2016-0228
First Posted: March 6, 2017    Key Record Dates
Last Update Posted: February 4, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: At this time, it is undecided if IPD will be made available to other researchers at the end of this study.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Sarah Boyd, Hartford Hospital:
pelvic organ prolapse
urinary catheters
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Retention
Pelvic Organ Prolapse
Pathological Conditions, Anatomical
Urination Disorders
Urologic Diseases